Another Fine Mess
April 25th 2011 Posted at Tobacco Politics
2 Comments
This is another fine mess we’ve gotten into.
You may not have seen this. Not many newspapers and other news outlets ran the story, but the Food and Drug Administration says it wants to visit tobacco manufacturers to “learn more about the business.”
Huh?
The FDA has had since 2009 to learn the tobacco business. It has been spending your tax dollars on who-knows-what and now they need to visit tobacco plants to learn from the horse’s mouth the ground floor operations.
Here’s how The Associated Press wrote it the other day:
“The federal agency’s 2-year-old Center for Tobacco Products is asking tobacco companies to invite it to tour farms and factories that grow or process tobacco.
“It says the visits are meant to help the agency better understand how each step in the process — from field to package — could influence the final product.
“The FDA wants to tour large and small cigarette factories, a smokeless tobacco plants, tobacco farms, a rolling-paper factory and a tobacco warehouse.
“The agency won the authority to regulate tobacco in 2009. Although the agency has the authority to visit most tobacco facilities, the tours are not official inspections. It said in its request that better understanding the industry ‘may be helpful.’
“Some of the people they’ve hired certainly know a lot about tobacco, (but) the odds that many or any of them have actually been on the inside of a manufacturing facility is probably pretty low,” said Ira Loss, an analyst with Washington Analysis who has covered the agency for three decades.
“The nation’s second-largest cigarette maker, Reynolds American Inc., intends to take the agency up on the request.
“‘We certainly think it’s important the FDA understand the practicalities of tobacco manufacturing,’ Reynolds spokesman David Howard said.
“Altria Group Inc., owner of the nation’s top cigarette company, Philip Morris USA, said it plans to respond but wouldn’t say whether that meant it would extend an invitation.
“Tobacco companies, in essence, will foot the bill through user fees the FDA charges them.”
Say, isn’t this a little like letting the fox in the hen house?
It also looks to me that some enterprising newspaper reporter somewhere would like to ask the FDA what they have been doing with all the tax money that has rolled in from tobacco revenue the past couple of years.
Has the tobacco tax revenue gone to salaries and to fix up nice digs for the tobacco czar, Lawrence Deyton, director of the Center for Tobacco Products?
The Center, you recall, oversees the implementation of the Family Smoking Prevention and Tobacco Control Act signed by President Obama in June 2009.
The FDA’s responsibilities under the law include setting performance standards, reviewing premarket applications for new and modified risk tobacco products, and establishing and enforcing advertising and promotion restrictions.
Seems to me that coming up on two years now, some enterprising reporter would like to ask some questions about what has the Center for Tobacco Products (CFTP) has been doing and why just now going to tobacco manufacturers for insight?
How many people are sucking off the taxpayer teat at the CFTP and what are their salaries? What have they done in the past two years besides hold “webinars” and send out notices? What about a little transparency, as people in Washington like to crow.
Show us the money and results!
I’m just saying.



